Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5900
+0.0050 (0.85%)
Jun 26, 2026, 3:59 PM AEST
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 204.08 million as of June 26, 2026. Its market cap has increased by 13.79% in one year.
Market Cap
204.08M
Enterprise Value
186.80M
Revenue
86.47M
Ranking
n/a
PE Ratio
54.94
Stock Price
0.59
Market Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 204.08M, a decrease of -49.62%. That is a compound annual growth rate of -10.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 204.08M | -20.07% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imricor Medical Systems | 659.26M |
| PolyNovo | 652.85M |
| EBR Systems | 166.71M |
| EMVision Medical Devices | 140.83M |
| SomnoMed | 117.21M |
| Lumos Diagnostics Holdings | 106.25M |
| Saluda Medical | 100.81M |
| Epiminder | 69.23M |